{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:46:28Z","timestamp":1782251188360,"version":"3.54.5"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T00:00:00Z","timestamp":1384300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0078730","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T23:05:09Z","timestamp":1384383909000},"page":"e78730","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":55,"title":["Clinical Significance of sIL-2R Levels in B-Cell Lymphomas"],"prefix":"10.1371","volume":"8","author":[{"given":"Noriaki","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyo","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Okikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Masunari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumu","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nishisaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Sadahira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keichiro","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Asaoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Arihiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,11,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.4049\/jimmunol.135.5.3172","article-title":"Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro","volume":"135","author":"LA Rubin","year":"1985","journal-title":"J Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.2741\/1461","article-title":"Soluble interleukin-2 receptor in cancer","volume":"9","author":"S Murakami","year":"2004","journal-title":"Front Biosci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood.V71.4.1021.1021","article-title":"Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease","volume":"71","author":"N Yasuda","year":"1988","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/1043-4666(90)90062-X","article-title":"The molecular basis for the generation of the human soluble interleukin 2 receptor","volume":"2","author":"LA Rubin","year":"1990","journal-title":"Cytokine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/1097-0142(19940601)73:11<2753::AID-CNCR2820731117>3.0.CO;2-X","article-title":"Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia","volume":"73","author":"S Kamihira","year":"1994","journal-title":"Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1200\/JCO.2011.38.2101","article-title":"Prognostic index for acute- and lymphoma-type adult T-cell leukemia\/lymphoma","volume":"30","author":"H Katsuya","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin&apos;s lymphoma. The International Non-Hodgkin&apos;s Lymphoma Prognostic Factors Project","volume":"329","author":"MA Shipp","year":"1993","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2141.2009.08065.x","article-title":"Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients","volume":"149","author":"L Arcaini","year":"2010","journal-title":"Br J Haematol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","article-title":"Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project","volume":"27","author":"M Federico","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s11899-009-0027-0","article-title":"Prognostic factors in low-grade non-Hodgkin lymphomas","volume":"4","author":"M Federico","year":"2009","journal-title":"Curr Hematol Malig Rep"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","article-title":"The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"109","author":"LH Sehn","year":"2007","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF02592278","article-title":"Soluble interleukin-2 receptor in hairy-cell leukemia: a reliable marker of disease","volume":"23","author":"A Ambrosetti","year":"1993","journal-title":"Int J Clin Lab Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/annonc\/mdn677","article-title":"Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy","volume":"20","author":"D Ennishi","year":"2009","journal-title":"Ann Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00432-004-0600-9","article-title":"Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin&apos;s lymphoma: in combination with the International Prognostic Index","volume":"131","author":"H Goto","year":"2005","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00277-011-1363-4","article-title":"Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens","volume":"91","author":"N Goto","year":"2012","journal-title":"Ann Hematol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1476-9255-6-31","article-title":"Cleavage of functional IL-2 receptor alpha chain (CD25) from murine corneal and conjunctival epithelia by MMP-9","volume":"6","author":"CS De Paiva","year":"2009","journal-title":"J Inflamm (Lond)"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2249.2007.03464.x","article-title":"Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships","volume":"150","author":"N El Houda Agueznay","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ccr.2007.11.032","article-title":"Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells","volume":"13","author":"GO Ahn","year":"2008","journal-title":"Cancer Cell"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1172\/JCI200422087","article-title":"An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis","volume":"114","author":"E Giraudo","year":"2004","journal-title":"J Clin Invest"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e31251","DOI":"10.1371\/journal.pone.0031251","article-title":"Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis","volume":"7","author":"D Liu","year":"2012","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1365-2141.2002.03255.x","article-title":"Matrix metalloproteinase-9 and vascular endothelial growth factor: a possible link in adult T-cell leukaemia cell invasion","volume":"116","author":"T Hayashibara","year":"2002","journal-title":"Br J Haematol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1182\/blood.V99.4.1341","article-title":"Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness","volume":"99","author":"N Mori","year":"2002","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"G Lenz","year":"2008","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1200\/JCO.2007.12.8298","article-title":"High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial","volume":"26","author":"D Canioni","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1349-7006.2009.01167.x","article-title":"Serum soluble interleukin-2 receptor level and immunophenotype are prognostic factors for patients with diffuse large B-cell lymphoma","volume":"100","author":"T Morito","year":"2009","journal-title":"Cancer Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.6600519","article-title":"Isolation and transmission of human retrovirus (human t-cell leukemia virus)","volume":"219","author":"M Popovic","year":"1983","journal-title":"Science"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.immuni.2010.11.011","article-title":"Neutrophils, from marrow to microbes","volume":"33","author":"N Borregaard","year":"2010","journal-title":"Immunity"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"21960","DOI":"10.1074\/jbc.M007997200","article-title":"Subcellular distribution and cytokine- and chemokine-regulated secretion of leukolysin\/MT6-MMP\/MMP-25 in neutrophils","volume":"276","author":"T Kang","year":"2001","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"A Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1440-1827.2010.02514.x","article-title":"Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL)","volume":"60","author":"D Niino","year":"2010","journal-title":"Pathol Int"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1182\/blood-2012-04-421057","article-title":"Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial","volume":"120","author":"KL Tan","year":"2012","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1158\/1078-0432.CCR-12-0129","article-title":"Tumor-associated macrophages in pediatric classical Hodgkin lymphoma: association with Epstein-Barr virus, lymphocyte subsets, and prognostic impact","volume":"18","author":"MH Barros","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis","volume":"4","author":"JW Pollard","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4049\/jimmunol.1000413","article-title":"Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility","volume":"185","author":"G Solinas","year":"2010","journal-title":"J Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"K Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"A Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"CP Hans","year":"2004","journal-title":"Blood"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"G Lenz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0078730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T13:25:28Z","timestamp":1688649928000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0078730"}},"subtitle":[],"editor":[{"given":"Joseph S.","family":"Pagano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,13]]},"references-count":38,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0078730","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,13]]}}}